McKesson Corporation (MCK) Financials
MCK Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 66.5 billion | 68.2 billion |
2023-09-30 | 66.1 billion | 67.6 billion |
2023-06-30 | 64.1 billion | 65.3 billion |
2023-03-31 | 62.3 billion | 63.8 billion |
MCK Free Cash Flow and Stock based compensation
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 100.0 million | 45.0 million |
2023-09-30 | 825.0 million | 46.0 million |
2023-06-30 | -1.2 billion | 875.0 million |
2023-03-31 | 3.1 billion | 162.0 million |
MCK Net Income
Date | Net Income |
---|---|
2023-12-31 | 630.0 million |
2023-09-30 | 703.0 million |
2023-06-30 | 997.0 million |
2023-03-31 | 826.0 million |
MCK Cash and Debt
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 2.0 billion | - | 1.7 billion |
2023-09-30 | 2.5 billion | 5.5 billion | 1.7 billion |
2023-06-30 | 2.6 billion | 5.6 billion | 1.8 billion |
2023-03-31 | 4.7 billion | 4.6 billion | 1.7 billion |
MCK Shares Outstanding
MCK Expenses
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 154.0 million | - | 5.0 billion | 2.5 billion |
2023-09-30 | 140.0 million | - | 4.2 billion | 2.1 billion |
2023-06-30 | 124.0 million | - | 3.7 billion | 1.9 billion |
2023-03-31 | 182.0 million | 89.0 million | 3.8 billion | 9.8 billion |
MCK Cost of Revenue
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 80.9 billion | 77.7 billion |
2023-09-30 | 77.2 billion | 74.1 billion |
2023-06-30 | 74.5 billion | 71.5 billion |
2023-03-31 | 68.9 billion | 65.8 billion |
MCK
List: Contenders
Price: $531.87
Dividend Yield: 0.00%
Forward Dividend Yield: 0.47%
Payout Ratio: 9.81%
Dividend Per Share: 2.48 USD
Earnings Per Share: 22.12 USD
P/E Ratio: 19.54
Exchange: NYQ
Sector: Healthcare
Industry: Medical Distribution
Volume: 449906
Ebitda: 998.0 millionMarket Capitalization: 68.7 billion
Average Dividend Frequency: 4
Years Paying Dividends: 38
DGR3: 23.01%
DGR5: 18.50%
DGR10: 14.41%
DGR20: 15.26%